Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 37 fludarabine phosphate 35 Mycophenolic Acid 33 Whole-Body Irradiation 32 Busulfan 24 Tacrolimus 22 fludarabine 21 Peripheral Blood Stem Cell Transplantation 20 Cyclosporine 20 Melphalan 17 Antilymphocyte Serum 13 Methotrexate 12 Filgrastim 12 Granulocyte Colony-Stimulating Factor 11 Cytarabine 11 Cord Blood Stem Cell Transplantation 11 Thiotepa 9 thymoglobulin 8 eltrombopag 8 Lenalidomide 7 Etoposide 7 Epoetin Alfa 7 Dalteparin 7 romiplostim 6 Darbepoetin alfa 6 Alemtuzumab 6 merphos 5 apixaban 5 Sirolimus 5 Radiotherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × voxelotor × Classical hematology × Clear all

NCT03036813 2023-07-27

GBT_HOPE

Pfizer

Phase 3 Completed

449 enrolled 17 charts 1 FDA

Classical hematology

Anemia, Sickle Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡